Santen Sees Potential In Myopia Market After Ryjunea Approval

 
• By Kevin Grogan
  
There are no approved pharmaceutical treatments for myopia available in the EU or the US. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Therapy Areas